9 research outputs found
Positive and Negative Regulation of Prostate Stem Cell Antigen Expression by Yin Yang 1 in Prostate Epithelial Cell Lines
Prostate cancer is influenced by epigenetic modification of genes involved in cancer development and progression. Increased expression of Prostate Stem Cell Antigen (PSCA) is correlated with development of malignant human prostate cancer, while studies in mouse models suggest that decreased PSCA levels promote prostate cancer metastasis. These studies suggest that PSCA has context-dependent functions, and could be differentially regulated during tumor progression. In the present study, we identified the multi-functional transcription factor Yin Yang 1 (YY1) as a modulator of PSCA expression in prostate epithelial cell lines. Increased YY1 levels are observed in prostatic intraepithelial neoplasia (PIN) and advanced disease. We show that androgen-mediated up-regulation of PSCA in prostate epithelial cell lines is dependent on YY1. We identified two direct YY1 binding sites within the PSCA promoter, and showed that the upstream site inhibited, while the downstream site, proximal to the androgen-responsive element, stimulated PSCA promoter activity. Thus, changes in PSCA expression levels in prostate cancer may at least partly be affected by cellular levels of YY1. Our results also suggest multiple roles for YY1 in prostate cancer which may contribute to disease progression by modulation of genes such as PSCA
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
Cyr61 has been reported to participate in the development and progression of various cancers; however, its role in prostate cancer (PCa) still remains poorly understood. In this study, we explored the function of Cyr61 in a series of malignant PCa cell lines, including LnCap, Du145, and PC3. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet assays demonstrated that Cyr61 was essential for the proliferation of PCa cells. Soft agar assay and xenograft analysis showed that downregulation of Cyr61 suppressed the tumorigenicity of Du145 cells both in vitro and in vivo. Either silencing the cellular Cyr61 by RNA interference or neutralising the endogenous Cyr61 by antibody inhibited the migration of Du145 cells. In contrast, purified protein of Cyr61 promoted the migration of LnCap cells in a dose-dependent manner. These results suggested that Cyr61 was involved in the migration of PCa cells. We also observed the accumulation of mature focal adhesion complexes associated with the impaired migration through Cyr61 downregulation. Also, further studies showed that Cyr61 regulated the level of activated Rac1 as well as its downstream targets, including phosphorylated JNK, E-cadherin, and p27kip1, which are key molecules involved in cell growth, migration, and invasion. The in vivo mouse tail vein injection experiment revealed that Cyr61 affected the metastatic capacity of Du145 cells, suggesting that Cyr61 was required for prostate tumour metastasis. Altogether, our results demonstrated that Cyr61 played an important role in the tumorigenicity and metastasis of PCa cells, which will benefit the development of therapeutic strategy for PCas
Validation of participatory appraisal for use in animal health information systems in Africa
Participatory appraisal (PA) is a methodology for problem description and analysis that has
been widely used in less developed countries (LDCs) since the 1980s. The use of PA by
veterinarians in LDCs has been restricted to mainly small-scale community-based animal
health projects. Adoption of PA by veterinarians, particularly those working for
government, was limited because of concerns about the reliability and validity of the
methods.
Three studies were conducted with pastoralist and agropastoralist communities in East
Africa to vaiidate PA, by comparison of data derived from PA with conventional veterinary
investigation and epidemiological information. In southern Sudan, research was conducted
on a chronic wasting syndrome in adult cattle in Dinka and Nuer communities; in Kenya,
research was conducted on bovine trypanosomiasis in Orma communities; and in Tanzania
research was conducted on possible association between a chronic heat intolerance
syndrome (HI) and foot and mouth disease (FMD).
Participatory appraisal methods, called matrix scoring, seasonal calendars and proportional
piling, were standardised and repeated to generate quantitative data. The level of agreement
between informant groups was assessed using the Kendal coefficient of concordance (Jf)..
Matrix scoring was adapted for use by veterinarians to enable comparison of veterinarian's
perceptions of disease signs and causes, with those of pastoralist informants. The data were
compared using direct visual assessment, hierarchical cluster analysis and multidimensional
scaling. Matrix scoring, seasonal calendars and proportional piling were judged to have
good validity and reliability.
In Tanzania, adaptation of proportional piling enabled calculation of the relative risk of HI
cases being observed in cattle herds with previous history of FMD, and demonstrated
significant association between HI and FMD. This finding was confirmed by detection of
antibody to non-structural proteins to FMP in herds with and without HI.
It was concluded that PA methods were reliable and valid methods for veterinary
epidemiology when used by trained PA practitioners in agropastoral and pastoral settings.
The methods were valuable for data collection and analysis, and for enabling greater
involvement of livestock keepers in veterinary service development and research.
Participatory appraisal could be further adapted to improve the design of primary veterinary
services and disease surveillance systems. In veterinary research, PA was considered to be
particularly useful during the exploratory phase of research and for generating research
hypotheses. It was also concluded that institutional changes were required for the
widespread adoption of PA by veterinarians in Africa
Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP
Although chromosome translocations are well-documented recurrent events in hematological malignancies and soft tissue sarcomas, their significance in carcinomas is less clear. We report here the molecular characterization of the reciprocal translocation t(1;15)(p22;q22) in the prostate carcinoma cell line, LNCaP. The chromosome 1 breakpoint was localized to a single BAC clone, RP11-290M5, by sequential FISH analysis of clones selected from the NCBI chromosome 1 map. This was further refined to a 580-bp region by Southern blot analysis. A 2.85-kb fragment spanning the der(1) breakpoint was amplified by long-range inverse PCR. The breakpoint on chromosome 1 was shown to lie between the CYR61 and the DDAH1 genes with the der(1) junctional sequence linking the CYR61 gene to the TSPAN3 (TM4SF8) gene on chromosome 15. Confirmatory PCR and FISH mapping of the der(15) showed loss of chromosome material proximal to the breakpoint on chromosome 15, containing the PSTPIP1 and RCN2 genes. On the available evidence we conclude that this translocation does not result in an in-frame gene fusion. Comparative expressed sequence hybridization (CESH) and comparative genomic hybridization (CGH) analysis, showed relative down-regulation of gene expression surrounding the breakpoint, but no gross change in genomic copy number. Real-time quantitative RT-PCR for genes around the breakpoint supported the CESH data. Therefore, here we may have revealed a gene down-regulation mechanism associated with a chromosome translocation, either through small deletion at the breakpoint or through another means of chromosome domain related gene regulation. <br/
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) remains a lethal malignancy despite much progress concerning its molecular characterization. PDA tumours harbour four signature somatic mutations(1-4) in addition to numerous lower frequency genetic events of uncertain significance(5). Here we use Sleeping Beauty (SB) transposon-mediated insertional mutagenesis(6,7) in a mouse model of pancreatic ductal preneoplasia(8) to identify genes that cooperate with oncogenic Kras(G12D) to accelerate tumorigenesis and promote progression. Our screen revealed new candidate genes for PDA and confirmed the importance of many genes and pathways previously implicated in human PDA. The most commonly mutated gene was the X-linked deubiquitinase Usp9x, which was inactivated in over 50% of the tumours. Although previous work had attributed a pro-survival role to USP9X in human neoplasia(9), we found instead that loss of Usp9x enhances transformation and protects pancreatic cancer cells from anoikis. Clinically, low USP9X protein and messenger RNA expression in PDA correlates with poor survival after surgery, and USP9X levels are inversely associated with metastatic burden in advanced disease. Furthermore, chromatin modulation with trichostatin A or 5-aza-2'-deoxycytidine elevates USP9X expression in human PDA cell lines, indicating a clinical approach for certain patients. The conditional deletion of Usp9x cooperated with Kras(G12D) to accelerate pancreatic tumorigenesis in mice, validating their genetic interaction. We propose that USP9X is a major tumour suppressor gene with prognostic and therapeutic relevance in PDA